[HTML][HTML] Does tuberculosis threaten our ageing populations?

R Byng-Maddick, M Noursadeghi - BMC infectious diseases, 2016 - Springer
Background The global population is ageing quickly and our understanding of age-related
changes in the immune system suggest that the elderly will have less immunological …

[HTML][HTML] Quantitative characterization of the T cell receptor repertoire of naïve and memory subsets using an integrated experimental and computational pipeline which …

T Oakes, JM Heather, K Best, R Byng-Maddick… - Frontiers in …, 2017 - frontiersin.org
The T cell receptor (TCR) repertoire can provide a personalized biomarker for infectious and
non-infectious diseases. We describe a protocol for amplifying, sequencing, and analyzing …

The impact of biological therapy on regulatory T cells in rheumatoid arthritis

R Byng-Maddick, MR Ehrenstein - Rheumatology, 2015 - academic.oup.com
Regulatory T cells (Treg) are functionally defective in patients with RA. Restoring their function
may not only control inflammation but also restore tolerance in these patients. Biologic …

Recurrent serious infections in patients with rheumatoid arthritis—results from the British Society for Rheumatology Biologics Register

S Subesinghe, AI Rutherford, R Byng-Maddick… - …, 2018 - academic.oup.com
Objectives To establish the rate of recurrent infection in RA patients recruited to the British
Society for Rheumatology Biologics Register – Rheumatoid Arthritis. Secondary objectives …

[HTML][HTML] Validation of immune cell modules in multicellular transcriptomic data

G Pollara, MJ Murray, JM Heather, R Byng-Maddick… - PloS one, 2017 - journals.plos.org
Numerous gene signatures, or modules have been described to evaluate the immune cell
composition in transcriptomes of multicellular tissue samples. However, significant diversity in …

Biologic prescribing decisions following serious infection: results from the British Society for Rheumatology Biologics Register—Rheumatoid Arthritis

S Subesinghe, AI Rutherford, R Byng-Maddick… - …, 2018 - academic.oup.com
Objectives To establish whether the decision to stop, continue or switch TNF inhibitor (TNFi)
therapy to a biologic drug with an alternative mode of action following a serious infection (SI) …

[HTML][HTML] Tumor necrosis factor (TNF) bioactivity at the site of an acute cell-mediated immune response is preserved in rheumatoid arthritis patients responding to anti …

R Byng-Maddick, CT Turner, G Pollara, M Ellis… - Frontiers in …, 2017 - frontiersin.org
The impact of anti-tumor necrosis factor (TNF) therapies on inducible TNF-dependent activity
in humans has never been evaluated in vivo. We aimed to test the hypothesis that patients …

Management of persistent inflammatory large joint monoarthritis

R Byng-Maddick, L Jeyalingam, A Keat - Clinical rheumatology, 2012 - Springer
Persistent inflammatory monoarthritis is inflammation of one joint, with symptoms lasting
beyond 3 months. Approximately 50 % of cases are self-limiting; others will transform into oligo- …

Infections in biological agents used in rheumatic disease

R Byng-Maddick, M Ehrenstein - British Journal of Hospital …, 2012 - magonlinelibrary.com
Immunosuppression and biological therapies are being used exponentially to treat
inflammatory arthritis and connective tissue diseases. This article discusses the potential …

[HTML][HTML] Options for taking time out of specialty training

R Byng-Maddick, K Walker-Bone - Clinical Medicine, 2016 - ncbi.nlm.nih.gov
Trainees in higher specialty training programmes may have the option to take time out of
their training programme to enhance or broaden their skills and perhaps develop a …